Steris Plc (NYSE:STE) had its price target increased by TD Securities from C$14.00 to C$16.00 in a research report released on Thursday, November 9th, StockTargetPrices.com reports. They currently have a buy rating on the medical equipment provider’s stock.
Other analysts have also recently issued reports about the company. BidaskClub cut Steris Plc from a strong-buy rating to a buy rating in a report on Monday, July 31st. KeyCorp reaffirmed a buy rating and set a $91.00 price objective on shares of Steris Plc in a report on Tuesday, October 17th. Zacks Investment Research raised Steris Plc from a hold rating to a buy rating and set a $101.00 price objective on the stock in a report on Monday, October 9th. Finally, Raymond James Financial, Inc. increased their price target on Steris Plc from $95.00 to $100.00 and gave the company an outperform rating in a report on Monday, October 16th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company’s stock. The company has an average rating of Hold and a consensus price target of $77.80.
Shares of Steris Plc (NYSE STE) traded down $0.68 during trading hours on Thursday, hitting $87.90. The company had a trading volume of 237,377 shares, compared to its average volume of 467,924. The company has a market cap of $7,496.52, a P/E ratio of 22.72 and a beta of 1.31. The company has a current ratio of 2.80, a quick ratio of 2.18 and a debt-to-equity ratio of 0.48. Steris Plc has a 52 week low of $64.37 and a 52 week high of $93.39.
Steris Plc (NYSE:STE) last posted its quarterly earnings results on Wednesday, November 1st. The medical equipment provider reported $0.94 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.95 by ($0.01). Steris Plc had a return on equity of 11.49% and a net margin of 5.59%. The business had revenue of $634.20 million during the quarter, compared to the consensus estimate of $629.02 million. During the same quarter in the previous year, the company earned $0.89 earnings per share. The company’s revenue for the quarter was down 1.9% compared to the same quarter last year. research analysts predict that Steris Plc will post 4.06 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 20th. Stockholders of record on Wednesday, November 22nd will be given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date of this dividend is Tuesday, November 21st. Steris Plc’s payout ratio is 73.81%.
In related news, VP John Adam Zangerle sold 3,650 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $88.00, for a total transaction of $321,200.00. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, October 4th. The shares were sold at an average price of $90.50, for a total value of $905,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 192,722 shares of company stock worth $16,913,753 in the last three months. Corporate insiders own 2.55% of the company’s stock.
Several large investors have recently made changes to their positions in the company. Janus Henderson Group PLC raised its stake in shares of Steris Plc by 1,972.4% in the second quarter. Janus Henderson Group PLC now owns 7,679,507 shares of the medical equipment provider’s stock worth $625,880,000 after purchasing an additional 7,308,950 shares during the last quarter. BlackRock Inc. raised its stake in shares of Steris Plc by 33.4% in the second quarter. BlackRock Inc. now owns 7,032,984 shares of the medical equipment provider’s stock worth $573,188,000 after purchasing an additional 1,760,879 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Steris Plc by 1.6% in the second quarter. Vanguard Group Inc. now owns 6,879,760 shares of the medical equipment provider’s stock worth $560,700,000 after purchasing an additional 107,644 shares during the last quarter. FMR LLC raised its stake in shares of Steris Plc by 33.1% in the second quarter. FMR LLC now owns 3,454,533 shares of the medical equipment provider’s stock worth $281,544,000 after purchasing an additional 859,228 shares during the last quarter. Finally, State Street Corp raised its stake in shares of Steris Plc by 53.2% in the second quarter. State Street Corp now owns 2,336,074 shares of the medical equipment provider’s stock worth $190,392,000 after purchasing an additional 811,622 shares during the last quarter. Hedge funds and other institutional investors own 91.79% of the company’s stock.
About Steris Plc
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with our FREE daily email newsletter.